Chris Moore

Jan 18, 2025 | elespanol.com | Chris Moore

Las empresas farmacéuticas están integrando cada vez más tecnologías de inteligencia artificial (IA) en sus estrategias comerciales, con un enfoque centrado en el cliente. Esta adopción no solo permite un engagement más personalizado, sino que impulsa la eficiencia operativa en múltiples niveles. Sin embargo, para aprovechar plenamente el potencial transformador de la IA, es esencial una estrategia clara que priorice la calidad y armonización de los datos.

Aug 15, 2024 | biorxiv.org | Kellie E. Smith |Laura Cowan |Paulina Flis |Chris Moore

AbstractThe duckweeds feature global distributions and diverse applications in phytoremediation and nutrition, as well as use in fundamental studies of development. Existing collections have minimal environmental data linked to natural habitats. Thus, there is a lack of understanding of natural variation in the context of native habitats. Here, a novel collection of 124 duckweed accessions from 115 sites across the United Kingdom were characterised by genome sequencing and ionomics.

May 16, 2024 | treasuryandrisk.com | Chris Moore |Chris O'Malley |Ross Todd

The purpose of performance measurement is to track how employees and their actions add value to an organization. For public companies, this value is typically reflected in shareholder returns and capital market valuations. But how can executives making operating decisions know how those decisions are going to be received by the market? If a new investment or acquisition adds $100 million in revenue, how will that affect the share price?

Apr 13, 2024 | biorxiv.org | Megan Cole |Panayiotis Anastasiou |Claudia Lee |Chris Moore

AbstractWe recently showed that lung tumor specific KRAS-G12C inhibition causes remodelling of the tumor immune microenvironment from cold to hot. As a result, KRAS-G12C inhibition is able to synergise with anti-PD-1 treatment, but only in tumor models that were already moderately responsive to immune checkpoint blockade at baseline.

Feb 29, 2024 | streetinsider.com | Jennifer Haworth |Chris Moore

Form 4 GLOBE LIFE INC. For: Feb 28 Filed by: Haworth Jennifer AllisonFebruary 29, 2024 3:55 PM ESTFORM4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the SecuritiesExchange Act of 1934or Section 30(h) of the Investment Company Act of1940OMB APPROVALOMB Number:3235-0287Expires:December 31, 2014Estimated average burdenhours per response:0.5Check this box if no longer subject to Section 16.